Form 4 for IMNM Immunome Inc.
Accepted 2025-09-11 00:00:00 ET · period of report 2025-09-10 · accession 0001415889-25-024319 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-11 | 2025-09-10 | IMNM | Higgins Jack | CSO | M - OptEx | $1.35 | +22.0K | 40.7K | +117% | +$29.7K |
| D | 2025-09-11 | 2025-09-10 | IMNM | Higgins Jack | CSO | M - OptEx | $0.00 | -22.0K | 151.8K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-10 | M | A | 22,000 | $1.35 | 40,729 | D | — | — | |
| 2 | Derivative | Employee Stock option (right to buy) | 2025-09-10 | M | D | 22,000 | $0.00 | 151,840 | D | $1.35 · — to 2032-06-23 | 22,000 Common Stock | (F1) 25% of the shares vested on May 1, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter. |